DocGo (NASDAQ:DCGO – Get Free Report)‘s stock had its “overweight” rating restated by equities research analysts at Cantor Fitzgerald in a research report issued on Monday,Benzinga reports.
Several other research firms have also recently weighed in on DCGO. Canaccord Genuity Group dropped their price target on shares of DocGo from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Wednesday, March 25th. Needham & Company LLC reissued a “buy” rating and set a $3.00 target price on shares of DocGo in a research note on Tuesday, March 17th. Finally, Stifel Nicolaus decreased their price target on DocGo from $4.00 to $2.50 and set a “buy” rating on the stock in a research note on Tuesday, March 17th. Three research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $2.38.
Get Our Latest Research Report on DCGO
DocGo Trading Up 2.6%
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Neuberger Berman Group LLC acquired a new stake in DocGo during the 4th quarter worth approximately $29,000. Cerity Partners LLC acquired a new position in shares of DocGo in the second quarter worth $37,000. Public Employees Retirement System of Ohio purchased a new stake in shares of DocGo during the fourth quarter worth $40,000. Engineers Gate Manager LP purchased a new stake in shares of DocGo during the second quarter worth $52,000. Finally, Royce & Associates LP acquired a new stake in shares of DocGo in the third quarter valued at $64,000. Hedge funds and other institutional investors own 56.44% of the company’s stock.
DocGo Company Profile
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Further Reading
- Five stocks we like better than DocGo
- Catching Falling Knives: Is Time to Buy These Beaten-Down Stocks?
- The Stars Are Aligning For Apple: Get Ready for $300
- 3 Small-Cap Stocks to Buy as the Russell 2000 Extends Its Rally
- Tapestry Stock Drops After Strong Quarter and Raised Outlook
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
